Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Ketorolac for Opioid-Induced Hypersensitivity
NCT00693160Phase 2Terminated
- Sponsor
- Wake Forest University
- Start
- Dec 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac in opioid-induced hyperalgesia (OIH), sponsored by Wake Forest University. Started Dec 2007; status: terminated.
02
Drugs
ketorolac
03
Conditions
opioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on NCT00693160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693160.